Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
EphB6 crosslinking results in costimulation of T cells
Hongyu Luo, … , Yulian Wu, Jiangping Wu
Hongyu Luo, … , Yulian Wu, Jiangping Wu
Published October 15, 2002
Citation Information: J Clin Invest. 2002;110(8):1141-1150. https://doi.org/10.1172/JCI15883.
View: Text | PDF
Article Aging

EphB6 crosslinking results in costimulation of T cells

  • Text
  • PDF
Abstract

Research Article

Authors

Hongyu Luo, Guang Yu, Yulian Wu, Jiangping Wu

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
EphB6 crosslinking enhances the T cell response to TCR stimulation. Repr...
EphB6 crosslinking enhances the T cell response to TCR stimulation. Representative results are shown. (a and b) MaxiSorp 96-well plates were coated overnight at 4°C with a suboptimal concentration of αCD3 mAb (clone OKT3, 0.2 μg/ml) along with various concentrations of αEphB6 mAb (clone 4F12) (a), or were coated with an optimal concentration of αEphB6 (4 μg/ml) along with various concentrations of αCD3 (b). MACS-purified T cells were cultured in these plates for 72 hours, and 3H-thymidine was added for the last 8 hours of culture. (c) MASC-purified T cells were cultured in these wells in the presence or absence of soluble EphB6-Fc or a control protein (control-Fc) (10 μg/ml) as inhibitor. (d and e) MaxiSorp 96-well plates were coated with α-CD3 plus α-EphB6, or with α-CD3 plus αCD28 (4 μg/ml) as described above. T cells were purified from PBMCs by MACS and subsequently fractionated into CD4+ cells, CD8+ cells, CD45RO+ cells, and CD45RO– cells (pure T cells depleted of CD45RO+ cells) using MACS beads. The cells were cultured for 1–3 days, and their thymidine uptake was measured for the last 8 hours of culture. (f) Costar 96-well plates were first coated with α-CD3 (0.2 μg/ml) overnight. After washing, the wells were incubated with mouse ephrinB2-Fc or a control recombinant protein with an Fc tag (control-Fc) (5 μg/ml or 10 μg/ml, as indicated) for 2 hours at 37°C followed by 2 hours on ice. MACS-purified T cells were cultured in the wells for 48 hours, and thymidine uptake was measured for the last 8 hours of culture. α, anti.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts